PMID- 27544714 OWN - NLM STAT- MEDLINE DCOM- 20170130 LR - 20181202 IS - 1878-3511 (Electronic) IS - 1201-9712 (Linking) VI - 51 DP - 2016 Oct TI - Paradoxical reaction in immunocompetent children with tuberculosis. PG - 15-18 LID - S1201-9712(16)31136-5 [pii] LID - 10.1016/j.ijid.2016.08.009 [doi] AB - BACKGROUND: A paradoxical reaction (PR) during anti-tuberculosis treatment is a phenomenon that is poorly studied in immunocompetent children. It is defined as a clinical or radiological worsening of pre-existing tuberculosis (TB) disease. METHODS: A retrospective descriptive study of children younger than 14 years of age was performed; these children developed PR during the years 2009 to 2014, following a diagnosis of TB. Demographic characteristics, microbiological results, treatment and outcome data were collected. RESULTS: Of 51 children diagnosed with TB, five (9.8%) developed a PR; four of these children had pulmonary TB and the remaining patient had miliary TB with central nervous system involvement. The PR occurred at a median of 42 days (range 23-53 days) after initiating therapy. Corticosteroids were started when PR was suspected, at a median dose of 1mg/kg/day. Clinical and radiological improvement was noted in all cases, with a median clinical regression time of 10.5 days (range 3-15 days) and a median radiological regression time of 45 days (range 26-105 days). No sequelae were described in any patient. CONCLUSIONS: PR in immunocompetent children during anti-tuberculosis treatment is not such an unusual reaction. Treatment with corticosteroids may be useful for the resolution of PR. CI - Copyright (c) 2016 The Authors. Published by Elsevier Ltd.. All rights reserved. FAU - Carazo Gallego, Begona AU - Carazo Gallego B AD - Infectious Diseases and Immunodeficiencies Unit, Department of Paediatrics, Malaga Regional University Hospital, Avenida Arroyo de los Angeles, s/n, Malaga, 29011, Spain. Electronic address: bcarazo002@gmail.com. FAU - Moreno-Perez, David AU - Moreno-Perez D AD - Infectious Diseases and Immunodeficiencies Unit, Department of Paediatrics, Malaga Regional University Hospital, Avenida Arroyo de los Angeles, s/n, Malaga, 29011, Spain. FAU - Nunez Cuadros, Esmeralda AU - Nunez Cuadros E AD - Infectious Diseases and Immunodeficiencies Unit, Department of Paediatrics, Malaga Regional University Hospital, Avenida Arroyo de los Angeles, s/n, Malaga, 29011, Spain. FAU - Mesa Fernandez, Alba AU - Mesa Fernandez A AD - Infectious Diseases and Immunodeficiencies Unit, Department of Paediatrics, Malaga Regional University Hospital, Avenida Arroyo de los Angeles, s/n, Malaga, 29011, Spain. FAU - Martin Cantero, Maria AU - Martin Cantero M AD - Infectious Diseases and Immunodeficiencies Unit, Department of Paediatrics, Malaga Regional University Hospital, Avenida Arroyo de los Angeles, s/n, Malaga, 29011, Spain. FAU - Obando Pacheco, Pablo AU - Obando Pacheco P AD - Infectious Diseases and Immunodeficiencies Unit, Department of Paediatrics, Malaga Regional University Hospital, Avenida Arroyo de los Angeles, s/n, Malaga, 29011, Spain. FAU - Urda Cardona, Antonio AU - Urda Cardona A AD - Infectious Diseases and Immunodeficiencies Unit, Department of Paediatrics, Malaga Regional University Hospital, Avenida Arroyo de los Angeles, s/n, Malaga, 29011, Spain. LA - eng PT - Journal Article DEP - 20160817 PL - Canada TA - Int J Infect Dis JT - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases JID - 9610933 RN - 0 (Adrenal Cortex Hormones) RN - 0 (Antitubercular Agents) SB - IM MH - Adrenal Cortex Hormones/therapeutic use MH - Antitubercular Agents/*therapeutic use MH - Child MH - Child, Preschool MH - Female MH - Humans MH - Male MH - Retrospective Studies MH - Tuberculosis/*drug therapy/physiopathology MH - Tuberculosis, Miliary/drug therapy MH - Tuberculosis, Pulmonary/microbiology OTO - NOTNLM OT - Children OT - Corticosteroids OT - Immunocompetent OT - Paradoxical reaction OT - Tuberculosis EDAT- 2016/10/26 06:00 MHDA- 2017/01/31 06:00 CRDT- 2016/08/22 06:00 PHST- 2016/03/31 00:00 [received] PHST- 2016/08/09 00:00 [revised] PHST- 2016/08/11 00:00 [accepted] PHST- 2016/10/26 06:00 [pubmed] PHST- 2017/01/31 06:00 [medline] PHST- 2016/08/22 06:00 [entrez] AID - S1201-9712(16)31136-5 [pii] AID - 10.1016/j.ijid.2016.08.009 [doi] PST - ppublish SO - Int J Infect Dis. 2016 Oct;51:15-18. doi: 10.1016/j.ijid.2016.08.009. Epub 2016 Aug 17.